<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">23605780</PMID>
        <DateCompleted>
            <Year>2013</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>12</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1534-6269</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2013</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Current oncology reports</Title>
                <ISOAbbreviation>Curr Oncol Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Exploring novel therapeutic targets in GIST: focus on the PI3K/Akt/mTOR pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn>386-95</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11912-013-0316-6</ELocationID>
            <Abstract>
                <AbstractText>Gastrointestinal stromal tumors (GISTs) are the most common soft tissue sarcoma, and most feature abnormalities in two genes encoding the receptor tyrosine kinases (RTKs), KIT, and PDGFRA. The RTK inhibitor imatinib revolutionized treatment in GIST; however, drug resistance remains a challenge. Constitutive autophosphorylation of RTKs is linked to phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway hyperactivation, which is central to oncogenic signaling, and known to be dysregulated in GIST. Preclinical experiments have confirmed that inhibiting the PI3K/Akt/mTOR pathway is a rational target for therapy. Early studies using mTOR inhibitors have shown limited success, which may be due to the activation of Akt that occurs following mTORC1 inhibition. Therefore, targeting PI3K or Akt, which lie upstream of mTORC1, may translate into more complete pathway inhibition. Several treatment strategies are currently being developed in phase 1 and 2 clinical trials. Compounds currently in development include pan-Class I PI3K inhibitors, dual PI3K/mTOR inhibitors, and Akt inhibitors. The aim of this review is to highlight the evidence for targeting PI3K/Akt/mTOR-dependent mechanisms in GIST and to evaluate the existing preclinical and clinical data supporting this strategy. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Shreyaskumar</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>The University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Blvd, Unit 450, Houston, TX 77030, USA. spatel@mdanderson.org</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Curr Oncol Rep</MedlineTA>
            <NlmUniqueID>100888967</NlmUniqueID>
            <ISSNLinking>1523-3790</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000081082">Phosphoinositide-3 Kinase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.1.1</RegistryNumber>
                <NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.1.1</RegistryNumber>
                <NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 2.7.11.1</RegistryNumber>
                <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005770" MajorTopicYN="N">Gastrointestinal Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D046152" MajorTopicYN="N">Gastrointestinal Stromal Tumors</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058990" MajorTopicYN="N">Molecular Targeted Therapy</DescriptorName>
                <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000081082" MajorTopicYN="Y">Phosphoinositide-3 Kinase Inhibitors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2013</Year>
                <Month>4</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2013</Year>
                <Month>4</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">23605780</ArticleId>
            <ArticleId IdType="doi">10.1007/s11912-013-0316-6</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Pathol. 2008 Sep;216(1):64-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18623623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Exp Clin Cancer Res. 2010 Dec 30;29:173</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21192792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2006 Sep;17 Suppl 10:x280-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17018739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2005 Jun 1;11(11):4182-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15930355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2003 Nov;2(11):1093-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14617782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2006 Oct 10;24(29):4764-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16954519</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2009 Aug 14;284(33):22067-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19535330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2005 Feb;128(2):270-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15685537</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2007 Mar 1;13(5):1367-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17332278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2009 Dec 15;15(24):7510-7518</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20008851</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pol Arch Med Wewn. 2008 Apr;118(4):216-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18575421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2008 Feb 1;26(4):620-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18235121</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2011 Apr;121(4):1231-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21490404</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2004 Sep 1;64(17):5913-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15342366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2012 Feb 15;130(4):959-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21445973</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 Aug 15;347(7):472-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12181401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Cancer Drug Targets. 2011 Jul;11(6):688-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21599631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2003 Jan 31;299(5607):708-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12522257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncologist. 2009 Feb;14(2):174-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19193781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 2002 May;33(5):459-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12094370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2004 Sep 25-Oct 1;364(9440):1127-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15451219</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2010 Feb 20;28(6):1075-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20085938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2009 Aug;8(8):627-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19644473</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Oncol. 2010 Oct;21(10):1990-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20507881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull Cancer. 2010 Jun;97(6):629-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20504759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Oncol. 2008;25(2):207-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18488160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2009 Aug;9(8):550-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19629070</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1998 Jan 23;279(5350):577-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9438854</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Cell Dev Biol. 2001;17:615-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11687500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta. 2010 Mar;1804(3):433-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20005306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 Mar 28;373(9669):1097-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19303137</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1542-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19164557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2000 Sep 15;18(18):3211-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10986053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Differ. 2003 Oct;10 (10 ):1165-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14502240</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2010 Nov;1(7):530-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21317449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cancer Res Clin Oncol. 2010 Jul;136(7):1065-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20043176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anticancer Res. 2011 Sep;31(9):3019-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21868553</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2007 Nov 29;26(54):7560-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17546049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Surg. 2006 Aug;244(2):176-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16858179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aging (Albany NY). 2011 Mar;3(3):192-222</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21422497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2011 Apr;11(4):289-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21430697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cancer. 2011 Nov 17;11(12):865-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22089421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Biochem. 1998;67:481-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9759495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2006 Oct 14;368(9544):1329-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17046465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2008 Sep 18;27(41):5486-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18794883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Transl Med. 2011 May 23;9:75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21605429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2003 Sep;125(3):660-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12949711</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2003 May 27;100(11):6706-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12754375</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Drug Targets. 2009 Oct;10(10):937-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19860642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Pathol Lab Med. 2004 Apr;128(4):421-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15043466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8387-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18550829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2011 Apr 1;71(7):2590-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21427355</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diagn Mol Pathol. 2011 Mar;20(1):22-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21326036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Lett. 2011 Dec 15;312(1):43-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21906875</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Oncol. 2012 Mar 10;30(8):765-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22271482</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 1998 May 29;273(22):13375-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9593664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 1999 Apr;23(4):377-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10199467</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
